Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Suzhou Fengbei Biotech Stock CoSHSE:603334 +1.66%40 Altman Z-Score is 9.44 as of Jul. 29, 2026, which is 17% below its 10-year median of 11.32. GuruFocus rates SHSE:603334 with a GF Score™ of 40/100. The stock has 4 warning signs investors should review. Among 235 Waste Management companies, Suzhou Fengbei Biotech Stock Co ranks better than 91.91% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 9.31 is strong.
Suzhou Fengbei Biotech Stock Co has a Altman Z-Score of 9.44, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Suzhou Fengbei Biotech Stock Co's Altman Z-Score or its related term are showing as below:
SHSE:603334'
s Altman Z-Score Range Over the Past 10 Years
Min: 9.31 Med: 11.32 Max: 13.11
Current: 9.31
During the past 6 years, Suzhou Fengbei Biotech Stock Co's highest Altman Z-Score was 13.11. The lowest was 9.31. And the median was 11.32.
Suzhou Fengbei Biotech Stock Co (SHSE:603334) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Fengbei Biotech Stock Co Altman Z-Score Chart
SHSE:603334 vs WM, RSG, WCN: Altman Z-Score Comparison
For the Waste Management subindustry, Suzhou Fengbei Biotech Stock Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzhou Fengbei Biotech Stock Co Altman Z-Score vs Waste Management Industry
For the Waste Management industry and Industrials sector, Suzhou Fengbei Biotech Stock Co's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Suzhou Fengbei Biotech Stock Co's Altman Z-Score falls into.
Suzhou Fengbei Biotech Stock Co Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a Altman Z-Score of 9.44 as of Jul. 29, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. This is 17% below median its historical median of 11.32. Over the past decade, Suzhou Fengbei Biotech Stock Co's Altman Z-Score has ranged from 9.31 to 13.11. According to the industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #19 out of 235 companies in the Waste Management industry, placing it in the top 8.1%.
Is Suzhou Fengbei Biotech Stock Co's Altman Z-Score too high?
Suzhou Fengbei Biotech Stock Co's current Altman Z-Score of 9.44 is 17% below median its 10-year median of 11.32. Over the past 10 years, this metric has ranged from a low of 9.31 to a high of 13.11. The Waste Management industry median Altman Z-Score is 1.90. Suzhou Fengbei Biotech Stock Co's value of 9.44 is 396.8% above this industry median. Based on the distribution chart, Suzhou Fengbei Biotech Stock Co ranks #19 out of 235 companies in the Waste Management industry, which is in the top quartile — a strong position relative to peers. Overall, Suzhou Fengbei Biotech Stock Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou Fengbei Biotech Stock Co's Altman Z-Score compare to WM and RSG?
According to the Waste Management industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #19 out of 235 companies for Altman Z-Score. This places Suzhou Fengbei Biotech Stock Co in the top 8% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 1.90. Suzhou Fengbei Biotech Stock Co's value of 9.44 is 396.8% above this benchmark. Historically, Suzhou Fengbei Biotech Stock Co's own Altman Z-Score has ranged from 9.31 to 13.11 over the past decade. While the company's 10-year median is 11.32 vs. the industry median of 1.90, Suzhou Fengbei Biotech Stock Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Waste Management company?
The median Altman Z-Score among Waste Management companies is 1.90, based on 235 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzhou Fengbei Biotech Stock Co's current Altman Z-Score of 9.44 is 396.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. For the Waste Management industry, the median Altman Z-Score is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzhou Fengbei Biotech Stock Co's current Altman Z-Score is 9.44, which is 17% below median its own 10-year median of 11.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Fengbei Biotech Stock Co stock overvalued right now?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a current Altman Z-Score of 9.44. The current Altman Z-Score is 9.44, which is 17% below median its 10-year median of 11.32 and 396.8% above the Waste Management industry median of 1.90. Suzhou Fengbei Biotech Stock Co's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Suzhou Fengbei Biotech Stock Co (SHSE:603334), the current Altman Z-Score is 9.44 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Suzhou Fengbei Biotech Stock Co Business Description
Suzhou Fengbei Biotech Stock Co Ltd is focused on the comprehensive utilization of waste oil and fat resources. The company is engaged in the research and development, production, and sales of industrial packaging materials, methyl oleate, and methylated soybean oil (excluding food products). It operates as an independent import and export agent for various commodities and technologies. The company's licensed projects include Fertilizer production, and General projects include Technical services, technical development, technical consultation, technical exchange, technology transfer, and technology promotion. It is into the research and development of bio-organic fertilizers, compound microbial fertilizers, and bio-pesticide technology.
40GF Score
Get the complete analysis for SHSE:603334
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603334 has been successfully added to your 
